Chendi Cui
Overview
Explore the profile of Chendi Cui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sekikawa A, Li M, Joshi N, Herbert B, Tilves C, Cui C, et al.
J Epidemiol
. 2024 Jul;
35(2):90-99.
PMID: 39034109
Background: A recent systematic review showed Japan's mortality from chronic obstructive pulmonary disease (COPD) is the lowest among 204 countries, despite notably higher smoking rates in men in Japan than...
2.
Cui C, Timbrook T, Polacek C, Heins Z, Rosenthal N
Front Med (Lausanne)
. 2024 May;
11:1325236.
PMID: 38818396
Background: Acute respiratory infections (ARIs) represent a significant public health concern in the U.S. This study aimed to describe the disease burden of ARIs and identify U.S. populations at high...
3.
Cui C, Feng C, Rosenthal N, Wade S, Curry L, Fu C, et al.
Leuk Lymphoma
. 2024 Apr;
65(7):922-931.
PMID: 38567630
The efficacy of chimeric antigen receptor (CAR) T-cell therapy for large B-cell lymphoma (LBCL) is well-established. This study, using the Premier PINC AI Healthcare Database, assessed hospital costs and healthcare...
4.
Cui C, Higashiyama A, Lopresti B, Ihara M, Aizenstein H, Watanabe M, et al.
Brain Sci
. 2021 Sep;
11(9).
PMID: 34573201
The Alzheimer's Disease Neuroimaging Initiative showed that Japanese had significantly lower brain Aβ burden than Americans among a cognitively normal population. This cross-sectional study aimed to compare vascular disease burden,...
5.
Sekikawa A, Higashiyama A, Lopresti B, Ihara M, Aizenstein H, Watanabe M, et al.
Alzheimers Dement (N Y)
. 2020 Oct;
6(1):e12089.
PMID: 33117881
Introduction: Equol, a metabolite of a soy isoflavone transformed by the gut microbiome, is anti-oxidant and anti-amyloidogenic. We assessed the associations of equol with white matter lesion normalized to total...
6.
Cui C, Mackey R, Shaaban C, Kuller L, Lopez O, Sekikawa A
Alzheimers Dement
. 2020 Aug;
16(10):1402-1411.
PMID: 32803916
Introduction: A body of literature reported associations between late-life general adiposity measures (eg, body mass index) and dementia. Little is known about the association of late-life body composition with dementia...
7.
Man B, Cui C, Zhang X, Sugiyama D, Barinas-Mitchell E, Sekikawa A
Eur J Nutr
. 2020 Jun;
60(2):603-614.
PMID: 32529287
Purpose: Some but not all randomized controlled trials (RCTs) of soy isoflavones showed their beneficial effect on arterial stiffness, a predictor of cardiovascular events, dementia, and all-cause mortality, independent of...
8.
Sekikawa A, Cui C, Sugiyama D, Fabio A, Harris W, Zhang X
Nutrients
. 2019 Nov;
11(11).
PMID: 31671524
A recent randomized controlled trial (RCT), the Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial (REDUCE-IT), reported that high-dose marine omega-3 fatty acids (OM3) significantly reduce cardiovascular disease (CVD) outcomes,...
9.
Cui C, Birru R, Snitz B, Ihara M, Kakuta C, Lopresti B, et al.
Nutr Rev
. 2019 Sep;
78(2):134-144.
PMID: 31504836
Context: The results of preclinical and observational studies support the beneficial effect of soy isoflavones on cognition. Objective: This review aimed to evaluate the effects of soy isoflavones on cognition...
10.
Sekikawa A, Ihara M, Lopez O, Kakuta C, Lopresti B, Higashiyama A, et al.
Curr Cardiol Rev
. 2018 Dec;
15(2):114-135.
PMID: 30516108
Background: Observational studies in Asia show that dietary intake of soy isoflavones had a significant inverse association with coronary heart disease (CHD). A recent randomized controlled trial (RCT) of soy...